Literature DB >> 1465198

Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropin-releasing factor in unstressed or stressed male rats.

F J Arnold1, M De Lucas Bueno, H Shiers, D C Hancock, G I Evan, J Herbert.   

Abstract

Corticotropin-releasing factor has an integrative role on the behavioral, endocrine and autonomic responses to stress. Immediate-early gene (c-fos) expression was used to determine patterns of neural activity in the limbic system following i.c.v. infusion of corticotropin-releasing factor. Either 250 or 1000 pmol corticotropin-releasing factor infused into the lateral ventricle of precannulated and handled male rats resulted in marked c-fos expression 60 or 120 min later in localized regions of the basal forebrain, including the ventrolateral septum, the dorsal and medial parvicellular divisions of the paraventricular nucleus, the central nucleus of the amygdala, and dorsal bed nucleus of the stria terminalis. Pre-infusion of alpha-helical corticotropin-releasing factor (2500 pmol), a competitive corticotropin-releasing factor antagonist of corticotropin-releasing factor, had no effect on immediate-early gene expression alone but reduced that elicited by exogenous i.c.v. corticotropin-releasing factor (250 pmol)--in some areas to control levels. Fifteen minutes of restraint stress, a situation in which corticotropin-releasing factor is released endogenously, also activated c-fos expression in a pattern that resembled corticotropin-releasing factor infusions but was not identical. There was enhanced expression in the dorsal and medial areas of the paraventricular nucleus, but not its magnocellular region, and increased expression in the ventrolateral septum; however, there was no detectable response on the central amygdala. Preinfusion of alpha-helical corticotropin-releasing factor (2500 pmol) had no significant effect on stress-induced c-fos expression in the ventrolateral septum or paraventricular nucleus. This suggests that corticotropin-releasing factor release may form only a part of the central neurochemical response to restraint stress. Rats given i.c.v. corticotropin-releasing factor (250 pmol) before restraint stress showed additive effects on c-fos in the ventrolateral septum but not in the paraventricular nucleus; the central nucleus of the amygdala reacted as if corticotropin-releasing factor alone had been infused. Corticosterone levels were raised by both stress and corticotropin-releasing factor, but pretreatment with alpha-helical corticotropin-releasing factor reduced them after either procedure, which correlates with c-fos expression in the paraventricular nucleus and ventrolateral septum. These results show that corticotropin-releasing factor induces a specific pattern of c-fos expression in localized regions of the amygdala, hypothalamus and septum, which may indicate a corresponding pattern of neural activation. Restraint, one form of stress, activates c-fos in a similar but not identical manner, suggesting that corticotropin-releasing factor may not be the only neuropeptide involved in the response to this stressor.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465198     DOI: 10.1016/0306-4522(92)90322-s

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Lesions of the medial geniculate nuclei specifically block corticosterone release and induction of c-fos mRNA in the forebrain associated with audiogenic stress in rats.

Authors:  S Campeau; H Akil; S J Watson
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

2.  Maternal separation enhances neuronal activation and cardiovascular responses to acute stress in borderline hypertensive rats.

Authors:  Brian J Sanders; Alan Anticevic
Journal:  Behav Brain Res       Date:  2007-05-24       Impact factor: 3.332

3.  Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.

Authors:  J C Bittencourt; P E Sawchenko
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

4.  Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?

Authors:  C T Wotjak; M Kubota; G Liebsch; A Montkowski; F Holsboer; I Neumann; R Landgraf
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

5.  Sex differences in circuits activated by corticotropin releasing factor in rats.

Authors:  Madeleine Salvatore; Kimberly R Wiersielis; Sandra Luz; David E Waxler; Seema Bhatnagar; Debra A Bangasser
Journal:  Horm Behav       Date:  2017-12-14       Impact factor: 3.587

6.  Acute Impact of Selected Pyridoindole Derivatives on Fos Expression in Different Structures of the Rat Brain.

Authors:  Romana Koprdova; Jana Osacka; Mojmir Mach; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.046

7.  c-fos expression in the amygdala: in vivo antisense modulation and role in anxiety.

Authors:  C Möller; O Bing; M Heilig
Journal:  Cell Mol Neurobiol       Date:  1994-10       Impact factor: 5.046

8.  Role of the septum in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex.

Authors:  Y Lee; M Davis
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

9.  Transsynaptic induction of c-fos in basal forebrain, diencephalic and midbrain neurons following AMPA-induced activation of the dorsal and ventral striatum.

Authors:  K J Page; B J Everitt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Sex differences in corticotropin releasing factor-evoked behavior and activated networks.

Authors:  Kimberly R Wiersielis; Brittany Wicks; Hannah Simko; Sarah R Cohen; Sabina Khantsis; Nausheen Baksh; David E Waxler; Debra A Bangasser
Journal:  Psychoneuroendocrinology       Date:  2016-07-28       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.